MiR-23b and miR-130b expression is downregulated in pituitary adenomas

Molecular and Cellular Endocrinology

Volumn 390, Issue 1-2, 2014, Pages 1-7

  Leone, Vincenza ^a   Langella, Concetta ^a   D'Angelo, Daniela ^a   Mussnich, Paula ^a   Wierinckx, Anne ^b,e   Terracciano, Luigi ^c   Raverot, Gerald ^d   Lachuer, Joel ^e   Rotondi, Sandra ^f   Jaffrain Rea, Marie Lise ^f,g   Trouillas, Jacqueline ^b,d   Fusco, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE LYON   (France)

^f UNIVERSITY OF L'AQUILA   (Italy)

^g IRCCS NEUROMED   (Italy)

Author keywords

CCNA2; HMGA2; MicroRNA; Pituitary adenoma

Indexed keywords

CYCLIN A2; HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MICRORNA 130B; MICRORNA 23B; THYROTROPIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN130 MICRORNA, HUMAN; MIRN23 MICRORNA, HUMAN;

ADULT; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CCNA2 GENE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GONADOTROPH ADENOMA; HMGA2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; NON FUNCTIONING PITUITARY ADENOMA; NONHUMAN; PRIORITY JOURNAL; RAT; 3' UNTRANSLATED REGION; ADENOMA; ANIMAL; BINDING SITE; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HYPOPHYSIS; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADENOMA; ANIMALS; BINDING SITES; CARCINOGENESIS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HMGA2 PROTEIN; HUMANS; MICRORNAS; PITUITARY GLAND; PITUITARY NEOPLASMS; RATS; RNA INTERFERENCE;

EID: 84898614413     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.03.002     Document Type: Article

References (41)

1. Amaral F.C., Torres N., Saggioro F., Neder L., Machado H.R., Silva W.A., Moreira A.C., Castro M. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 2009, 94:320-323.
2. Arafah B.M., Nasrallah M.P. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr. Relat. Cancer 2001, 8:287-305.
3. Asa S.L., Ezzat S. Molecular basis of pituitary development and cytogenesis. Front Horm. Res. 2004, 32:1-19.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bottoni A., Zatelli M.C., Ferracin M., Tagliati F., Piccin D., Vignali C., Calin G.A., Negrini M., Croce C.M., Degli Uberti E.C. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J. Cell. Physiol. 2007, 210:370-377.
6. Butz H., Likó I., Czirják S., Igaz P., Korbonits M., Rácz K., Patócs A. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioningpituitary adenomas. Pituitary 2011, 14:112-124.
7. Chen Y.X., Li Q., Wang C.D., Su Z.P., Li W.Q., Chen X.B., Wu Z.B. Differential expression analysis of prolactinoma-related microRNAs. Zhonghua Yi Xue Za Zhi 2012, 92:320-323.
8. Chen Z., Chen L.Y., Dai H.Y., Wang P., Gao S., Wang K. MiR-301a promotes pancreatic cancer cell proliferation by directly inhibiting bim expression. J. Cell. Biochem. 2012, 113:3229-3235.
9. D'Angelo D., Palmieri D., Mussnich P., Roche M., Wierinckx A., Raverot G., Fedele M., Croce C.M., Trouillas J., Fusco A. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J. Clin. Endocrinol. Metab. 2012, 97. E1128-1138.
10. De Martino I., Visone R., Wierinckx A., Palmieri D., Ferraro A., Cappabianca P., Chiappetta G., Forzati F., Lombardi G., Colao A., Trouillas J., Fedele M., Fusco A. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009, 69:1844-1850.
11. Elenkova A.P., Atanassova I., Kirilov G., Vasilev V., Kalinov K., Zacharieva S. Transforming growth factor beta 1 (TGF-β1) is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study). Eur. J. Endocrinol. 2013, 169:299-306.
12. Fabbri M., Croce C.M., Calin G.A. MicroRNAs. Cancer J. 2008, 14:1-6.
13. Fedele M., Battista S., Kenyon L., Baldassarre G., Fidanza V., Klein-Szanto A.J.P., Parlow A.F., Visone R., Pierantoni G.M., Outwater E., Santoro M., Croce C.M., Fusco A. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002, 21:3190-3198.
14. Fedele M., Visone R., De Martino I., Troncone G., Palmieri D., Battista S., Ciarmiello A., Pallante P., Arra C., Melillo R.M., Helin K., Croce C.M., Fusco A. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006, 9:459-471.
15. Finelli P., Pierantoni G.M., Giardino D., Losa M., Rodeschini O., Fedele M., Valtorta E., Mortini P., Croce C.M., Larizza L., Fusco A. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res. 2002, 62:2398-2405.
16. Formosa R., Xuereb-Anastasi A., Vassallo J. Aip regulates cAMP signalling and GH secretion in GH3 cells. Endocr. Relat. Cancer 2013, 20:495-505.
17. Gadelha M.R., Trivellin G., Hernández Ramírez L.C., Korbonits M. Genetics of pituitary adenomas. Front Horm. Res. 2013, 41:111-140.
18. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25:387-392.
19. Katsuno Y., Lamouille S., Derynck R. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 2013, 25:76-84.
20. Kovaleva V., Mora R., Park Y.J., Plass C., Chiramel A.I., Bartenschlager R., Döhner H., Stilgenbauer S., Pscherer A., Lichter P., Seiffert M. MiRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012, 72:1763-1772.
21. Leone V., D'Angelo D., Pallante P., Croce C.M., Fusco A. Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3. J. Clin. Endocrinol. Metab. 2012, 97:3292-3301.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Lloyd, R.V., Kovacs, K., Young, Jr W.F., Farrel, W.E., Asa, S.L., Trouillas, J., Kontogeorgos, G., Sano, T., Scheithauer, B., Horvath, E., 2004. Pituitary tumours: introduction. In chapter 1: tumours of the pituitary. Pathology and genetics of tumours of endocrine organs. World Hearth Organization Classification of Tumours. Delellis RA, Lloyd RV, Heitz PU, Eng C (Eds.), IARC Press, Lyon, p. 10-13.
24. Lopes M.B. Growth hormone-secreting adenomas: pathology and cell biology. Neurosurg. Focus 2010, 29:E2.
25. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J. Clin. Invest. 2003, 112:1603-1618.
26. Miska E.A. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 2005, 15:563-568.
27. Nishizawa H., Fukuoka H., Iguchi G., Inoshita N., Yamada S., Takahashi Y. AIP mutation identified in a patient with acromegaly caused by pituitary somatotroph adenoma with neuronal choristoma. Exp. Clin. Endocrinol. Diabetes 2013, 121:295-299.
28. Palmieri D., D'Angelo D., Valentino T., De Martino I., Ferraro A., Wierinckx A., Fedele M., Trouillas J., Fusco A. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 2012, 23(31):3857-3865.
29. Paris O., Ferraro L., Grober O.M., Ravo M., De Filippo M.R., Giurato G., Nassa G., Tarallo R., Cantarella C., Rizzo F., Di Benedetto A., Mottolese M., Benes V., Ambrosino C., Nola E., Weisz A. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 2012, 31:4196-4206.
30. Pierantoni G.M., Finelli P., Valtorta E., Giardino D., Rodeschini O., Esposito F., Losa M., Fusco A., Larizza L. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr. Relat. Cancer 2005, 12:867-874.
31. Qian Z.R., Asa S.L., Siomi H., Siomi M.C., Yoshimoto K., Yamada S., Wang E.L., Rahman M.M., Inoue H., Itakura M., Kudo E., Sano T. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod. Pathol. 2009, 22:431-441.
32. Salvi A., Sabelli C., Moncini S., Venturin M., Arici B., Riva P., Portolani N., Giulini S.M., De Petro G., Barlati S. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. FEBS J. 2009, 276:2966-2982.
33. Scapoli L., Palmieri A., Lo Muzio L., Pezzetti F., Rubini C., Girardi A., Farinella F., Mazzotta M., Carinci F. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int. J. Immunopathol. Pharmacol. 2010, 23:1229-1234.
34. Scheithauer B.W., Gaffey T.A., Lloyd R.V., Sebo T.J., Kovacs K.T., Horvath E., Yapicier O., Young W.F., Meyer F.B., Kuroki T., Riehle D.L., Laws E.R. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 2006, 59:341-353.
35. Shi W., Gerster K., Alajez N.M., Tsang J., Waldron L., Pintilie M., Hui A.B., Sykes J., P'ng C., Miller N., McCready D., Fyles A., Liu F.F. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res. 2011, 71:2926-2937.
36. Tateno T., Zhu X., Asa S.L., Ezzat S. Chromatin remodeling and histone modifications in pituitary tumors. Mol. Cell. Endocrinol. 2010, 15(326):66-70.
37. Tong A.W., Fulgham P., Jay C., Chen P., Khalil I., Liu S., Senzer N., Eklund A.C., Han J., Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther. 2009, 16:206-216.
38. Trouillas J., Girod C., Sassolas G., Claustrat B. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors. Semin. Diagn. Pathol. 1986, 3:42-57.
39. Yacqub-Usman K., Richardson A., Duong C.V., Clayton R.N., Farrell W.E. The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nat. Rev. Endocrinol. 2012, 24(8):486-494.
40. Yam C.H., Fung T.K., Poon R.Y. Cyclin A in cell cycle control and cancer. Cell. Mol. Life Sci. 2002, 59:1317-1326.
41. Yang X.C., Tian L.L., Wu H.L., Jiang X.Y., Du L.Q., Zhang H., Wang Y.Y., Wu H.Y., Li D.G., She Y., Liu Q.F., Fan F.Y., Meng A.M. Expression of miRNA-130a in nonsmall cell lung cancer. Am. J. Med. Sci. 2010, 340:385-388.